Inappropriate Grading of Adverse Events in Cancer Clinical Trials-Reply

JAMA Oncol. 2019 Feb 1;5(2):269-270. doi: 10.1001/jamaoncol.2018.5871.

Authors

Valerie Cristina¹, Murielle Mauer², Anna Dorothea Wagner¹

Affiliations

¹ Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
² Statistics Department, EORTC Headquarters, Brusells, Belgium.

PMID: 30543369
DOI: 10.1001/jamaoncol.2018.5871

No abstract available

Publication types

Comment

MeSH terms

Humans
Neoplasms*
Retrospective Studies